Author： Fox Robert I
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.12, Iss.2, 2003-02, pp. : 247-254
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Sjogren’s syndrome: models of pathogenesis and treatment targets
By Derk Chris T
Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 11, 2005-11 ,pp. :
Access to resources
Recommend
Anti-CD20 Antibody in Primary Sjogren’s Syndrome Management
Current Pharmaceutical Biotechnology, Vol. 15, Iss. 6, 2014-06 ,pp. :
Epigenetics and Sjogren's Syndrome
Current Pharmaceutical Biotechnology, Vol. 13, Iss. 10, 2012-08 ,pp. :
Mouse Models of Primary Sjogren’s Syndrome
Current Pharmaceutical Design, Vol. 21, Iss. 18, 2015-06 ,pp. :